■ 学術雑誌
|
原著
|
|
1.
|
吉田明史、海堀昌樹、藤澤七海、石塚まりこ、住山房央、八田雅彦、小坂久、松井康輔、荏原充宏、関本貢嗣：
がん薬物療法とDrug Delivery System : レンバチニブ内包ナノファイバーシートの開発.
関西医科大学雑誌
75
：1
-5
, 2024
|
|
2.
|
Tada T, Kumada T, Hiraoka A, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Nishikawa H, Tsuji K, Ishikawa T, Tajiri K, Koshiyama Y, Toyoda H, Ogawa C, Hatanaka T, Kakizaki S, Kawata K, Ohama H, Tada F, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Nishimura T, Imai M, Kosaka H, Naganuma A, Matono T, Aoki T, Kuroda H, Yata Y, Koizumi Y, Nakamura S, Enomoto H, Kaibori M, Hiasa Y, Kudo M; Real‐life Practice Experts for HCC (RELPEC) Study Group; Hepatocellular Carcinoma Experts from 48 clinics in Japan (HCC 48) Group.：
Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real-world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial.
Alimentary pharmacology & therapeutics
60
(2)
：233
-245
, 2024
|
|
3.
|
Ikoma T, Matsumoto T, Boku S, Motoki Y, Kinoshita H, Kosaka H, Kaibori M, Inoue K, Sekimoto M, Fujisawa T, Iwai H, Naganuma M, Tanizaki H, Hisamatsu Y, Okada H, Kurata T.：
Safety of immune checkpoint inhibitors in patients aged over 80 years: a retrospective cohort study.
Cancer immunology, immunotherapy : CII
73
(7)
：126
, 2024
|
|
4.
|
Naganuma A, Kakizaki S, Hiraoka A, Tada T, Hatanaka T, Kariyama K, Tani J,
Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri
K, Toyoda H, Ogawa C, Nishikawa H, Nishimura T, Kawata K, Kosaka H, Hirooka M,
Yata Y, Ohama H, Kuroda H, Matono T, Aoki T, Kanayama Y, Tanaka K, Tada F, Nouso
K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M,
Nakamura S, Enomoto H, Kaibori M, Hiasa Y, Kudo M, Kumada T.：
Evaluation of Treatment Outcomes Using dNLR and GNRI in Combination Therapy With Atezolizumab and Bevacizumab for Hepatocellular Carcinoma.
Cancer medicine
14
(2)
：e70618
, 2025
|
|
5.
|
Ohama H, Hiraoka A, Tada T, Hirooka M, Kariyama K, Hatanaka T, Tani J, Takaguchi K, Atsukawa M, Itobayashi E, Nishimura T, Tsuji K, Tajiri K, Ishikawa T, Yasuda S, Toyoda H, Fukunishi S, Ogawa C, Kakizaki S, Shimada N, Naganuma A, Kawata K, Kosaka H, Kuroda H, Matono T, Yata Y, Ochi H, Tada F, Nouso K, Morishita A, Itokawa N, Okubo T, Arai T, Tsutsui A, Nagano T, Yokohama K, Nishikawa H, Imai M, Koizumi Y, Nakamura S, Iijima H, Kaibori M, Hiasa Y, Kumada T; Representing the Real‐life Practice Experts for HCC Study Group with Hepatocellular Carcinoma experts from 48 clinics in Japan (RELPEC/HCC 48 Group)：
Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
Cancer reports (Hoboken, N.J.)
7
(4)
：e2042
, 2024
|
|
6.
|
Lai TT, Ishida M, Kosaka H, Matsui K, Matsushima H, Yamamoto H, Kiguchi G,
Nguyen KV, Inoue K, Takada M, Kato H, Hirose Y, Yoshii K, Kaibori M.：
The Prognostic Impact of Adipophilin Expression on Long-Term Survival Following Liver Resection in Patients with Colorectal Liver Metastases.
Cancers
16
(22)
：3827
, 2024
|
|
7.
|
Murai K, Hikita H, Kodama T, Kaibori M, Nishimura Y, Tatsumi T, Yamada T, Kanto T, Mochida S, Takehara T.：
The impact of the COVID-19 pandemic on hepatocellular carcinoma diagnosis and treatment in Japan - a multicenter collaborative observational study.
Hepatology research
54
(5)
：439
-450
, 2024
|
|
8.
|
Kaibori M, Yoshii K, Lai TT, Matsushima H, Tatsuishi W, Inada R, Matsugu Y,
Komeda K, Asakuma M, Tanaka K, Sato H, Yamada T, Miyasaka T, Hasegawa Y, Matsui
R, Takehara K, Ko S, Yamato I, Washizawa N, Taniguchi H, Kimura Y, Ishibashi N,
Akagi Y, Hiki N, Higuchi T, Shingai T, Kamei T, Okamoto H, Nagakawa Y, Takishita
C, Kohri T, Matsui K, Nabeya Y, Fukatsu K, Miyata G.：
Prospective Survey of Postoperative Pain in Japan: A Multicenter, Observational Study.
Journal of clinical medicine
14
(4)
：1130
, 2025
|
|
9.
|
Rossari F, Tada T, Suda G, Shimose S, Kudo M, Yoo C, Cheon J, Finkelmeier F, Lim HY, Presa J, Masi G, Bergamo F, Amadeo E, Vitiello F, Kumada T, Sakamoto N, Iwamoto H, Aoki T, Chon HJ, Himmelsbach V, Iavarone M, Cabibbo G, Montes M, Foschi FG, Vivaldi C, Solda C, Sho T, Niizeki T, Nishida N, Steup C, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Hiraoka A, Tada F, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Imai M, Kosaka H, Naganuma A, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Persano M, Foti S, Camera S, Stefanini B, Scartozzi M, Cascinu S, Casadei-Gardini A, Rimini,M：
Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a real-world, multicenter study.
Liver Cancer(S. Karger)
13
(5)
：522
-536
, 2024
|
|
10.
|
Shinkawa, H; Kaibori, M; Ueno, M; Yasuda, S; Ikoma, H; Aihara, T; Nakai, T; Kinoshita, M; Kosaka, H; Hayami, S; Matsuo, Y; Morimura, R; Nakajima, T; Nobori, C; Ishizawa, T：
Impact of Diabetes Mellitus and Obesity Comorbidities on Survival Outcomes after Hepatocellular Carcinoma Resection: A Multicenter Retrospective Study.
Liver Cancer(S. Karger)
14
(1)
：80
-91
, 2024
|
|
11.
|
Rimini M, Stefanini B, Tada T, Suda G, Shimose S, Kudo M, Finkelmeier F, Yoo
C, Presa J, Amadeo E, Genovesi V, De Grandis MC, Iavarone M, Marra F, Foschi F,
Tamburini E, Rossari F, Vitiello F, Bartalini L, Soldà C, Tovoli F, Vivaldi C,
Lonardi S, Silletta M, Kumada T, Sakamoto N, Iwamoto H, Aoki T, Himmelsbach V,
Montes M, Hiraoka A, Sho T, Niizeki T, Nishida N, Steup C, Hirooka M, Kariyama
K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa
T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T,
Kakizaki S, Shimada N, Kawata K, Tada F, Ohama H, Nouso K, Morishita A, Tsutsui
A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Kosaka H, Naganuma A, Koizumi
Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Persano M, Camera S, Foti S,
Aldrighetti L, Cascinu S, Casadei-Gardini A, Piscaglia F.：
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab.
Liver international
44
(5)
：1108
-1125
, 2024
|
|
12.
|
Promsorn P, Yamaguchi T, Kosaka H, Aoi K, Yoshida K, Matsushima H, Matsui K,
Shimoda S, Kaibori M, Naganuma M.：
Efficacy of lenvatinib and transarterial chemoembolization combination therapy in patients with hepatocellular carcinoma administered an insufficient dose of early lenvatinib.
Molecular and clinical oncology
21
(3)
：63
, 2024
|
|
13.
|
Van Nguyen, Khanh; Matsui, Kosuke; Kosaka, Hisashi; Matsushima, Hideyuki; Yamamoto, Hidekazu; Lai, Tung Thanh; Inoue, Kyoko; Takada, Moriyasu; Tada, Fujimasa; Hiraoka, Atsushi; Hatanaka, Takeshi; Tada, Toshifumi; Kumada, Takashi; Kato, Hiroki; Yoshii, Kengo; Yamaguchi, Takashi; Shimoda, Shinji; Naganuma, Makoto; Kaibori, Masaki：
Cachexia Index as a Prognostic Indicator in Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy.
Oncology
：Online ahead of print
, 2025
|
|
14.
|
Hiraoka A, Kudo M, Tada T, Hatanaka T, Kakizaki S, Kariyama K, Ohama H, Tsuji K, Ishikawa T, Takaguchi K, Itobayashi E, Toyoda H, Matono T, Yata Y, Ogawa C, Naganuma A, Tani J, Atsukawa M, Nishimura T, Tajiri K, Kawata K, Kosaka H, Kuroda H, Hirooka M, Nishikawa H, Tada F, Nakamura S, Kanayama Y, Nouso K, Tanaka H, Tanaka K, Imai M,
Tsutsui A, Nagano T, Aoki T, Koshiyama Y, Morishita A, Itokawa N, Okubo T, Arai T, Fukunishi S, Noritake H, Nakamura Y, Yoshida O, Enomoto H, Kaibori M, Hiasa Y, Kumada T; Real-life Practice Experts for HCC.：
The Current Status of Tumor Markers as Biomarkers in the Era of Immunotherapy for Hepatocellular Carcinoma: Alpha-Fetoprotein Alone Is Not Sufficient.
Oncology.
, 2025
|
|
15.
|
Nakamura T, Masuda A, Kako M, Enomoto H, Kaibori M, Fujita Y, Tanizawa K, Ioji T, Fujimori Y, Fukami K, Hazama T, Iwamoto H, Kako Y, Kobayashi K, Koga H, Nagafuji K, Ohtake T, Suzuki H, Takashima T, Tsukiyama T, Uojima H, Yamahara K, Yamakado K, Yamamoto H, Yoh K, Yoshihara S, Kawamoto A, Nishiguchi S, Kobayashi S, Torimura T, Kawaguchi T.：
Hepatic arterial infusion of autologous CD34+ cells for hepatitis C virus-related decompensated cirrhosis: A multicenter, open-label, exploratory randomized controlled trial.
Regenerative Therapy
27
：455
-463
, 2024
|
|
16.
|
Nakatake R, Funatsuki T, Koshikawa Y, Okuyama T, Ishizaki M, Takekita Y, Kato
M, Kitade H：
C reactive protein albumin ratio as a new predictor of postoperative delirium after cholecystectomy for acute cholecystitis.
Scientific reports
14
(1)
：21704
, 2024
|
|
17.
|
Ohama H, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M,
Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H,
Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N,
Kawata K, Naganuma A, Kosaka H, Matono T, Kuroda H, Yata Y, Tanaka H, Nishikawa
H, Shibata H, Tada F, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N,
Okubo T, Arai T, Imai M, Koizumi Y, Nakamura S, Iijima H, Kaibori M, Hiasa Y,
Kumada T.：
Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib.
Scientific reports
15
(1)
：72
, 2025
|
|
18.
|
Kosaka H, Matsui K, Ikeura T, Ito T, Ohe C, Kono Y, Matsushima H, Yamamoto H,
Sekimoto M, Kaibori M.：
Prognostic impact of combination therapy with gemcitabine and cisplatin plus S-1 and subsequent conversion surgery for initially unresectable upper biliary tract cancers.
Surgery today
55
(3)
：351
-359
, 2025
|
|
19.
|
Persano M, Rimini M, Tada T, Suda G, Shimose S, Kudo M, Rossari F, Yoo C, Cheon J, Finkelmeier F, Lim HY, Presa J, Masi G, Bergamo F, Amadeo E, Vitiello F, Kumada T, Sakamoto N, Iwamoto H, Aoki T, Chon HJ, Himmelsbach V, Iavarone MA, Cabibbo G, Montes M, Foschi FG, Vivaldi C, Soldà C, Sho T, Niizeki T, Nishida N,
Steup C, Bruccoleri M, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Hiraoka A, Tada F, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Imai M, Kosaka H, Naganuma A, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Foti S, Camera S, Piscaglia F, Scartozzi M, Cascinu S, Casadei-Gardini A.：
Adverse Events as Potential Predictive Factors of Activity in Patients with Advanced HCC Treated with Atezolizumab Plus Bevacizumab.
Targeted oncology
19
(4)
：645
-659
, 2024
|
|
20.
|
Yamamoto H, Isono K, Honda M, Sugawara Y, Inomata Y, Hibi T.：
Impact of Altered Graft Position During Living Donor Liver Retransplantation and its Outcomes.
Transplantation proceedings
57
(2)
：284
-291
, 2025
|
|
症例報告
|
|
1.
|
Nakatake R, Kitade H, Ishizaki M, Yanagida H, Okuyama T, Uemura Y, Sekimoto M.：
Giant hemorrhagic pancreatic pseudocyst with suspected cystic pancreatic tumor: a case report.
Journal of surgical case reports
2024
(6)
：rjae393
, 2024
|
|
